Company Summit Therapeutics plc London S.E.
Equities
GB00BN40HZ01
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 20-11-10 |
Robert Duggan
CEO | Chief Executive Officer | 79 | 19-11-30 |
Director of Finance/CFO | 46 | 19-11-30 | |
Allen Yang
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-15 |
Dave Gancarz
IRC | Investor Relations Contact | - | 20-10-31 |
Bhaskar Anand
AUD | Comptroller/Controller/Auditor | 46 | - |
Campbell Hair
HRO | Human Resources Officer | - | 20-09-30 |
Betty Chang
PRN | Corporate Officer/Principal | - | 21-05-31 |
Urte Gayko
LAW | General Counsel | 53 | 21-11-02 |
Shelley Spray
PRN | Corporate Officer/Principal | 59 | 21-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Duggan
CEO | Chief Executive Officer | 79 | 19-11-30 |
Robert Booth
BRD | Director/Board Member | 70 | 22-09-27 |
Director of Finance/CFO | 46 | 19-11-30 | |
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 20-11-10 |
Mostafa Ronaghi
BRD | Director/Board Member | 55 | 04-10 |
Kenneth Clark
BRD | Director/Board Member | 65 | 21-10-06 |
Director/Board Member | 63 | 22-11-14 | |
Urte Gayko
LAW | General Counsel | 53 | 21-11-02 |
Michelle Xia
BRD | Director/Board Member | 57 | 23-01-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 701,979,596 | 83,228,173 ( 11.86 %) | 0 | 11.86 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+15.85% | 122B | |
+18.91% | 113B | |
+6.99% | 22.84B | |
-18.63% | 20.72B | |
-13.76% | 16.39B | |
-15.85% | 16.51B | |
-43.53% | 15.83B | |
+1.75% | 13.49B | |
+28.07% | 11.67B |